General American Investors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-261,780
| Closed | -$21.9M | – | 67 |
|
|
2024
Q4 | $21.9M | Hold |
261,780
| – | – | 1.52% | 20 |
|
|
2024
Q3 | $19.2M | Hold |
261,780
| – | – | 1.32% | 23 |
|
|
2024
Q2 | $17.9M | Buy |
261,780
+1,341
| +0.5% | +$91.8K | 1.25% | 20 |
|
|
2024
Q1 | $18M | Hold |
260,439
| – | – | 1.29% | 20 |
|
|
2023
Q4 | $18.7M | Hold |
260,439
| – | – | 1.48% | 19 |
|
|
2023
Q3 | $13.6M | Hold |
260,439
| – | – | 1.22% | 25 |
|
|
2023
Q2 | $16.5M | Hold |
260,439
| – | – | 1.44% | 21 |
|
|
2023
Q1 | $14.1M | Sell |
260,439
-23,000
| -8% | -$1.25M | 1.33% | 24 |
|
|
2022
Q4 | $15M | Hold |
283,439
| – | – | 1.47% | 23 |
|
|
2022
Q3 | $13.2M | Hold |
283,439
| – | – | 1.37% | 28 |
|
|
2022
Q2 | $16.2M | Hold |
283,439
| – | – | 1.63% | 20 |
|
|
2022
Q1 | $17.3M | Hold |
283,439
| – | – | 1.42% | 25 |
|
|
2021
Q4 | $14.8M | Sell |
283,439
-67,365
| -19% | -$3.53M | 1.16% | 30 |
|
|
2021
Q3 | $13.1M | Hold |
350,804
| – | – | 1.11% | 35 |
|
|
2021
Q2 | $14.3M | Buy |
350,804
+3,307
| +1% | +$135K | 1.2% | 30 |
|
|
2021
Q1 | $11.8M | Hold |
347,497
| – | – | 1.1% | 34 |
|
|
2020
Q4 | $11.1M | Hold |
347,497
| – | – | 1.09% | 33 |
|
|
2020
Q3 | $8.92M | Buy |
347,497
+80,970
| +30% | +$2.08M | 1.03% | 32 |
|
|
2020
Q2 | $6.84M | Hold |
266,527
| – | – | 0.87% | 34 |
|
|
2020
Q1 | $4.1M | Sell |
266,527
-65,000
| -20% | -$999K | 0.55% | 40 |
|
|
2019
Q4 | $11.4M | Sell |
331,527
-10,000
| -3% | -$343K | 1.04% | 36 |
|
|
2019
Q3 | $2.55M | Buy |
341,527
+41,585
| +14% | +$311K | 0.25% | 62 |
|
|
2019
Q2 | $3.89M | Hold |
299,942
| – | – | 0.37% | 58 |
|
|
2019
Q1 | $3.65M | Hold |
299,942
| – | – | 0.36% | 59 |
|
|
2018
Q4 | $3.42M | Buy |
+299,942
| New | +$3.42M | 0.36% | 59 |
|